Search - tctmd.com

Displaying 181 - 200 of 1588

Sort: Relevancy | Date

Presentation TCT 2024

How Can Clinical Trials Mobilize the Diversity Efforts?

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

What am I Most Anticipating in Upcoming Clinical Trials?

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

Presenter: Behnood Bikdeli

October 29, 2024

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Presenter: Tobias Rheude

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

Presentation TCT 2024

The EARLY TAVR Trial Editorial Commentary

Presenter: Bernard Prendergast

October 28, 2024

Presentation TCT 2024

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Presenter: Mark Dweck

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

Presenter: Nicolas Van Mieghem

October 28, 2024

Presentation TCT 2024

TCT 616: Wire-Assisted Percutanoeus Mitral Commisuratomy Is Significantly Faster Than the Tradidtional Inoue Balloon Technique: A Randomized Clinical Trial

Presenter: Chala Oljira

October 28, 2024

Presentation TCT 2024

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

Presenter: Philippe Genereux

October 28, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Advertisement

How Can Clinical Trials Mobilize the Diversity Efforts?

What am I Most Anticipating in Upcoming Clinical Trials?

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

The EARLY TAVR Trial Editorial Commentary

Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial

TCT 616: Wire-Assisted Percutanoeus Mitral Commisuratomy Is Significantly Faster Than the Tradidtional Inoue Balloon Technique: A Randomized Clinical Trial

Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content